retatrutide is a glp 3 Triple Agonist Peptides Explained: Retatrutide, GLP-3, and the Future of Metabolic Research GLP-3 RETATRUTIDE - MVP Peptides

1994 ;76:1636-42 69 -Scholte HR ea J Clin Chem Clin Biochem.1990;28:351-7 70 -Tein I ea

Letelier ME, Izquierdo P, Godoy L, Lepe AM, Fandez M

Clinical effect of modified Liuwei Dihuang pill combined with Metformin in the treatment of senile type 2 diabetes of kidney Yin deficiency type

Both semaglutide and some antidepressants can cause nausea, vomiting, or constipation, which might be more pronounced when used together

Get baseline bloodwork including comprehensive metabolic panel, lipid panel, HbA1c, thyroid panel, and inflammatory markers

Patients with type 2 diabetes, especially those with cardiovascular disease, chronic kidney disease, obesity, or NAFLD, may benefit from GLP-1 receptor agonists as part of their treatment regimen